OCTAVE SPECIALTY GROUP INC
For the period ended Mar 31, 2026. Filed May 6, 2026.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Mar 31, 2026 · Filed May 6, 2026
OSG$5.41+2.7%Stored close · as of Nov 10, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Consolidated Statements of Stockholders' Equity (Unaudited)
| Three months ended March 31, 2026 and 2025 | ||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Stockholders' Equity · Mezzanine | ||||||||||||||
| Octave Specialty Group, Inc. · Equity | ||||||||||||||
| (Dollars in thousands) · Total · PreferredStock · CommonStock · Additional Paid-inCapital · AccumulatedOtherComprehensiveIncome · RetainedEarnings · CommonStock Heldin Treasury,at Cost · Non-redeemableNCI (1) · Redeemable NCI (1) | ||||||||||||||
| Balance at December 31, 2025 | $833,185 | $— | $489 | $369,860 | $8,483 | $370,431 | $(33,473) | $117,395 | $252,981 | |||||
| Total net income (loss) | (4,843) | — | — | — | — | (6,851) | — | 2,008 | 1,980 | |||||
| Total other comprehensive income (loss) | (9,436) | — | — | — | (7,259) | — | — | (2,177) | (4,193) | |||||
| Stock-based compensation | 4,722 | — | — | 4,722 | — | — | — | — | — | |||||
| Cost of shares repurchased | — | — | — | — | — | — | — | — | — | |||||
| Cost of shares (acquired) issued under equity plan | (272) | — | — | — | — | (636) | 364 | — | — | |||||
| Changes to noncontrolling interest | 10,218 | — | — | 5,681 | — | 807 | — | 3,730 | (54,799) | |||||
| Balance at March 31, 2026 | $833,574 | $— | $489 | $380,263 | $1,224 | $363,751 | $(33,109) | $120,956 | $195,969 | |||||
| Balance at December 31, 2024 | $996,119 | $— | $489 | $331,007 | $(188,436) | $683,643 | $(28,339) | $197,755 | $199,402 | |||||
| Total net income (loss) | (44,995) | — | — | — | — | (46,391) | — | 1,396 | 258 | |||||
| Total other comprehensive income (loss) | 58,110 | — | — | — | 53,407 | — | — | 4,703 | 5,658 | |||||
| Stock-based compensation | 2,349 | — | — | 2,349 | — | — | — | — | — | |||||
| Cost of shares repurchased | (3,122) | — | — | — | — | (3,122) | — | — | ||||||
| Cost of shares (acquired) issued under equity plan | (1,605) | — | — | — | — | (3,121) | 1,516 | — | — | |||||
| Changes to noncontrolling interest | (40,852) | — | — | — | — | (10,825) | — | (30,027) | 40,143 | |||||
| Balance at March 31, 2025 | $966,004 | $— | $489 | $333,356 | $(135,029) | $623,306 | $(29,945) | $173,827 | $245,461 | |||||
| (1) NCI = Noncontrolling interest | ||||||||||||||
| Octave Specialty Group, Inc. | 5 | First Quarter 2026 Form 10-Q |
|---|
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.